Lung cancer is a major public health problem. In the United States, 31% of cancer deaths in men and 26% of cancer deaths in women are secondary to lung cancer. The overall prognosis remains poor. Just over one in eight lung cancer patients will be living 5 years after their diagnosis. Most cases of lung cancer would be prevented if people did not smoke tobacco products. Unfortunately, data on worldwide tobacco consumption suggest that lung cancer will remain an epidemic for years to come. Recent advances in early detection and targeted therapies have changed evaluation and treatment paradigms, leading to a meaningful impact on patient outcomes.
Lung cancer is the leading cause of cancer-related mortality in both men and women. It surpassed colon cancer in the early 1950s in men and breast cancer in the late 1980s in women. Mortality rates in men declined significantly in the 1990s, whereas a slow increase occurred in women. These rates again parallel the smoking patterns of these two groups (Figures 2 and 3). There were an estimated 158,590 deaths in 2008 in the United States secondary to lung cancer. This means that lung cancer accounts for approximately 29% of all cancer deaths. In men, lung cancer becomes the leading cause of cancer-related mortality from age 40 onward. In women, lung cancer surpasses breast cancer in those 60 years and older.
Small Cell Lung Cancer clinic
At the time of diagnosis, approximately 30% of patients with SCLC will have tumors confined to the hemithorax of origin, the mediastinum, or the supraclavicular lymph nodes. These patients are designated as having limited-stage disease (LD). Patients with tumors that have spread beyond the supraclavicular areas are said to have extensive-stage disease (ED).SCLC is more responsive to chemotherapy and radiation therapy than other cell types of lung cancer; however, a cure is difficult to achieve because SCLC has a greater tendency to be widely disseminated by the time of diagnosis.
Comprehensive Cancer Center
The University of Chicago Medicine Comprehensive Cancer Center, we know that a cancer diagnosis can be life changing. Seeing new patients quickly, and helping them understand the disease and best treatment options are some ways we put minds at ease. With more than 200 cancer specialists, innovative treatments, leading-edge research, and clinical trials not available elsewhere, we’re attacking cancer from every angle.
Elkhart General Hospital
Elkhart General Hospital has been designated a Lung Cancer Screening Center by the American College of Radiology (ACR). EGH is one of just two facilities with this designation in Indiana. The ACR Lung Cancer Screening Center designation is a voluntary program that recognizes facilities that have committed to practice safe, effective diagnostic care for individuals at the highest risk for lung cancer.
Palmetto General Hospital
Mark Twain knew how hard it is to quit smoking. “Quitting smoking is easy. I’ve done it a thousand times,” he once said. It’s not easy to quit when nicotine withdrawal sets in within hours of the last cigarette. Coping with dizziness, depression, anxiety, irritability, headaches, tiredness, increased appetite, weight gain and sleep disturbances can be quite difficult. But those symptoms are much easier to manage than the alternative health problems caused by smoking.Long-term risks related to smoking range from lung cancer and heart disease, to stomach ulcers, acid reflux, gum disease and serious breathing problems. The negative health impact of smoking can not only steal quality of life, but also shorten a person’s lifespan. According to the U.S. Centers for Disease Control and Prevention, men and women who smoke lose an average of 14 years of life.
MD Anderson Cancer Center
MD Anderson Proton Therapy Center has an extensive team of cancer experts including radiation oncologists, nurses, radiation therapists, medical dosimetrists, physicists and other cancer professionals all dedicated to helping patients fight cancer. Because the center is part of MD Anderson, patients get the benefit of cancer research in addition to our team’s extensive expertise in treating patients with proton therapy. This depth and breadth of experience in both treating cancer and treating cancer with proton therapy has allowed us to further develop ways to help patients who have cancer in different areas of the body.